3K3A-APC demonstrates safety in clinical trial for acute ischemic stroke
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug...
List view / Grid view
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug...
During the Global Drug Delivery and Formulation Summit 2018, ADM-SIO will give a technical presentation about “Tackling the challenge of natural variability related to plant-based pharmaceutical ingredients” on 13 March...
Siemens AG and Perceptive Engineering Ltd announce a partnership which offers Perceptive’s PharmaMV and Siemens Simatic Sipat software products closely integrated to provide a versatile solution for advanced control and optimisation applications in both continuous and batch pharmaceutical manufacturing...
Scientists in California have undertaken studies that have demonstrated the effectiveness of a sophisticated algorithm in preventing the spread of infectious diseases. The application of AI allows authorities to identify the best use of resources and highlight subtle interaction points that might otherwise be missed.
Using AI and machine learning techniques, researchers have developed a new computational tool to screen patients with common retinal diseases, potentially speeding diagnoses and treatment...
MEMPHYS will work closely with the NHS, academia and industry to enable the rapid and widespread implementation of a host of new diagnostic and therapeutic technologies.
Major international study – comprising largest amount of unpublished data to date – has found that antidepressants are more effective than placebos for short-term treatment of acute depression in adults.
Data from the Phase I study of collaborative industry partnership AMP are now available, meaning scientists can benefit from access to important research about Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Circumventing evolution in cell factories can pave the way for commercialising new biobased chemicals to large-scale.
An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial...
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials.
Market leaders in temperature-controlled microscopy and leaders in sample characterization solutions, Linkam Scientific Instruments, reports on work from users in Singapore and Swansea to characterize perovskites, an exciting material with increasing numbers of applications in photovoltaics. Linkam is a sponsor of the 2018 International Conference on Perovskite Thin Film Photovoltaics…
Researchers have developed a sensing method with the potential to significantly contribute to early detection of cancer and diabetes...
An international team of scientists has developed a water-soluble warped nanographene, that is biocompatible and shows promise for fluorescent cell imaging...